SCHEMBL20398337

SCHEMBL20398337

CCCCCCCCCCCCCCCCCCOC(=O)CC(C)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.58
NPSR1 Q6W5P4 2/20 0.50
RAD52 P43351 1/20 0.50
FAAH O00519 1/20 0.49
ACE2 Q9BYF1 1/20 0.49
DGKA P23743 1/20 0.48
HTR2C P28335 1/20 0.47
MAPT P10636 2/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HCAR2 Q8TDS4 2/20 0.46
EPHX1 P07099 1/20 0.46
TSHR P16473 2/20 0.44
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43
NOD1 Q9Y239 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20398340 1.00 NAAA (0.58) NAAANPSR1RAD52FAAHACE2
SCHEMBL20398329 1.00 NAAA (0.58) NAAANPSR1RAD52FAAHACE2
SCHEMBL20184174 0.98 NAAA (0.55) NAAANPSR1RAD52FAAHACE2
SCHEMBL18291942 0.93 NAAA (0.47) NAAANPSR1RAD52FAAHACE2
SCHEMBL12526892 0.87 NAAA (0.60) NAAANPSR1RAD52FAAHDGKA
SCHEMBL12527404 0.87 NAAA (0.60) NAAANPSR1RAD52FAAHDGKA
SCHEMBL14587119 0.87 NAAA (0.60) NAAANPSR1RAD52FAAHDGKA
SCHEMBL12524471 0.87 NAAA (0.60) NAAANPSR1RAD52FAAHDGKA
SCHEMBL21478224 0.87 NAAA (0.60) NAAANPSR1RAD52FAAHDGKA
SCHEMBL21474644 0.87 NAAA (0.60) NAAANPSR1RAD52FAAHDGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108024950-B Method for enriching phellinus igniarius seed element of karanja oil 碧昂赛恩斯公司 2021-05-11 CN disclosed
EP-3598999-A1 METHOD FOR ENRICHING KARANJA OIL Biosynthis (FR) 2020-01-29 EP disclosed
US-10245220-B2 Process for pongamol enrichment of karanja oil BIOSYNTHIS (FR) 2019-04-02 US disclosed
US-20180207070-A1 PROCESS FOR PONGAMOL ENRICHMENT OF KARANJA OIL BIOSYNTHIS (FR) 2018-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10245220-B2 Process for pongamol enrichment of karanja oil CBX3, PAOX, CBX8 NAAA 3194/4885NPSR1 1982/4885RAD52 12/4885
US-20180207070-A1 PROCESS FOR PONGAMOL ENRICHMENT OF KARANJA OIL CBX3, PAOX, CBX8 NAAA 3194/4885NPSR1 1982/4885RAD52 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.